Skip to main content
Top

Open Access 30-09-2024 | Amyotrophic Lateral Sclerosis | Original Article

Clinical and epidemiological characteristics of amyotrophic lateral sclerosis in an Egyptian cohort

Authors: Radwa Soliman, Enass Onbool, Kareem Omran, Nagia Fahmy

Published in: Neurological Sciences

Login to get access

Abstract

Objective

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder associated with progressive loss of motor neurons. It is a growing and underestimated disease, prompting this epidemiological study to describe the characteristics of ALS in Egyptian patients.

Methods

This is a prospective hospital based study. ALS patients were recruited consecutively from Neuromuscular Unit in Ain Shams university Hospital from December 2018 to June 2023. Demographic data and disease related parameters were recorded.

Results

203 ALS patients had a mean age of onset equal 39 years and an inter quartile range IQR of (28.00–51.00). 76% of the cases were spinal onset ALS. Median disease duration was 2 years with IQR of (1–4 years); male to female ratio was 2.5:1; 18% of patients were familial ALS (FALS), while 19% were Juvenile ALS (JALS). Median diagnostic delay was 12 ± (6–36) months. Median Amyotrophic Lateral Sclerosis Functional Rating Scale Revised scores (ALSFRS-R) at presentation was 34.5 IQR of (26.00–40.00). Also, the mean rate of disease progression ALSFRS-R decline [points/month] was 0.76 ± 0.51.

Conclusion

Our cohort was characterized by a younger age of onset, male predominance, more familial cases, within average Initial ALSFRS-R scores as well as diagnostic delay. Juvenile ALS patients were much more common in our population. These findings suggest an influential presence of genetic and epigenetic factors affecting the clinical phenotype of Egyptian ALS patients.
Literature
1.
go back to reference Longinetti E, Wallin AR, Samuelson K et al (2018) The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener 19:528–537CrossRefPubMed Longinetti E, Wallin AR, Samuelson K et al (2018) The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener 19:528–537CrossRefPubMed
2.
go back to reference Jun KY, Park J (2019) Oh KW et al Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry 90:395–403CrossRefPubMed Jun KY, Park J (2019) Oh KW et al Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry 90:395–403CrossRefPubMed
3.
go back to reference Turgut N, Birgili O, VarolSaracoglu G et al (2019) An epidemiologic investigation of amyotrophic lateral sclerosis in Thrace, Turkey, 2006–2010. Amyotroph Lateral Scler Frontotemporal Degener 20:100–106CrossRefPubMed Turgut N, Birgili O, VarolSaracoglu G et al (2019) An epidemiologic investigation of amyotrophic lateral sclerosis in Thrace, Turkey, 2006–2010. Amyotroph Lateral Scler Frontotemporal Degener 20:100–106CrossRefPubMed
4.
go back to reference Leighton DJ, Newton J, Stephenson LJ et al (2019) Changing epidemiology of motor neurone diseases in Scotland. J Neurol 266:817–825CrossRefPubMed Leighton DJ, Newton J, Stephenson LJ et al (2019) Changing epidemiology of motor neurone diseases in Scotland. J Neurol 266:817–825CrossRefPubMed
6.
go back to reference Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B (2016) Epidemiology of amyotrophic lateral sclerosis: a review of literature. Rev Neurol 172:37–45CrossRefPubMed Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B (2016) Epidemiology of amyotrophic lateral sclerosis: a review of literature. Rev Neurol 172:37–45CrossRefPubMed
8.
go back to reference Robinson KM, Lacey SC, Grugan P, Glosser G, Grossman M, McCluskey LF (2006) Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six month longitudinal study. J Neurol Neurosurg Psychiatry 77:668–670CrossRefPubMedPubMedCentral Robinson KM, Lacey SC, Grugan P, Glosser G, Grossman M, McCluskey LF (2006) Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six month longitudinal study. J Neurol Neurosurg Psychiatry 77:668–670CrossRefPubMedPubMedCentral
9.
go back to reference Goutman SA, Chen KS, Paez-Colasante X, Feldman EL (2018) Emerging understanding of the genotype–phenotype relationship in amyotrophic lateral sclerosis. Handb Clin Neurol 148:603–623CrossRefPubMed Goutman SA, Chen KS, Paez-Colasante X, Feldman EL (2018) Emerging understanding of the genotype–phenotype relationship in amyotrophic lateral sclerosis. Handb Clin Neurol 148:603–623CrossRefPubMed
10.
go back to reference Marin B, Logroscino G, Boumédiene F, Labrunie A, Couratier P, Babron MC et al (2016) Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol 31(3):229–245CrossRefPubMed Marin B, Logroscino G, Boumédiene F, Labrunie A, Couratier P, Babron MC et al (2016) Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol 31(3):229–245CrossRefPubMed
12.
go back to reference Lekoubou A, Echouffo-Tcheugui JB, Kengne AP (2014) Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review. BMC Public Health 14:653CrossRefPubMedPubMedCentral Lekoubou A, Echouffo-Tcheugui JB, Kengne AP (2014) Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review. BMC Public Health 14:653CrossRefPubMedPubMedCentral
13.
go back to reference Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 1(5):293–299 Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 1(5):293–299
14.
go back to reference Ben Hamida M, Hentati F (1984) Maladie de Charcot et scl_erose lat_erale amyotrophique juv_enile. Rev Neurol 140:202–206PubMed Ben Hamida M, Hentati F (1984) Maladie de Charcot et scl_erose lat_erale amyotrophique juv_enile. Rev Neurol 140:202–206PubMed
15.
go back to reference Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A (2002) Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 3:15–21CrossRefPubMed Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A (2002) Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 3:15–21CrossRefPubMed
17.
go back to reference Rashed HR, Tork MA, Soliman R, Serag R, Fahmy N (2021) Arabic adaptation and validation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R): egyptian study. Amyotroph Lateral Scler Frontotemporal Degener 3–4:220–222CrossRef Rashed HR, Tork MA, Soliman R, Serag R, Fahmy N (2021) Arabic adaptation and validation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R): egyptian study. Amyotroph Lateral Scler Frontotemporal Degener 3–4:220–222CrossRef
18.
go back to reference Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R et al (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135(3):847–852CrossRefPubMedPubMedCentral Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R et al (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135(3):847–852CrossRefPubMedPubMedCentral
21.
25.
go back to reference Luna J, Diagana M, AitAissa L et al (2019) Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study. J Neurol, Neurosurg, Psychiatry 90:20–29CrossRefPubMed Luna J, Diagana M, AitAissa L et al (2019) Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study. J Neurol, Neurosurg, Psychiatry 90:20–29CrossRefPubMed
28.
go back to reference Imounan F, Lahbouje S, Hsaini Y, Regragui W, Ben Haddou EA, Benomar A et al (2015) Aspects cliniques et environnementaux de la scl_erose lat_erale amyotrophique chez une population marocaine: _etude de 60 cas. Tunisie M_edicale. 93:365–70 Imounan F, Lahbouje S, Hsaini Y, Regragui W, Ben Haddou EA, Benomar A et al (2015) Aspects cliniques et environnementaux de la scl_erose lat_erale amyotrophique chez une population marocaine: _etude de 60 cas. Tunisie M_edicale. 93:365–70
31.
go back to reference Benjaminsen E, Alstadhaug KB, Gulsvik M, Baloch FK, Odeh F (2018) Amyotrophic lateral sclerosis in Nordland County, Norway, 2000–2015: prevalence, incidence, and clinical features. Amyotroph Lateral Scler Frontotemporal Degener 19:522–527CrossRefPubMed Benjaminsen E, Alstadhaug KB, Gulsvik M, Baloch FK, Odeh F (2018) Amyotrophic lateral sclerosis in Nordland County, Norway, 2000–2015: prevalence, incidence, and clinical features. Amyotroph Lateral Scler Frontotemporal Degener 19:522–527CrossRefPubMed
32.
go back to reference De Marchi F, Sarnelli MF, Solara V et al (2019) Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis. Acta Neurol Scand 139:438–445CrossRefPubMed De Marchi F, Sarnelli MF, Solara V et al (2019) Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis. Acta Neurol Scand 139:438–445CrossRefPubMed
35.
go back to reference Samadhiya S, Sardana V, Bhushan B, Maheshwari D, Goyal R, Pankaj AA (2022) Assessment of therapeutic response of edaravone and riluzole combination therapy in amyotrophic lateral sclerosis patients. Ann Indian Acad Neurol. 25(4):692–697CrossRefPubMedPubMedCentral Samadhiya S, Sardana V, Bhushan B, Maheshwari D, Goyal R, Pankaj AA (2022) Assessment of therapeutic response of edaravone and riluzole combination therapy in amyotrophic lateral sclerosis patients. Ann Indian Acad Neurol. 25(4):692–697CrossRefPubMedPubMedCentral
36.
go back to reference Stevic Z, Kostic-Dedic S, Peric S, Dedic V, Basta I, Rakocevic-Stojanovic V et al (2016) Prognostic factors and survival of ALS patients from Belgrade. Serbia Amyotroph Lateral Scler Frontotemporal Degener 17:508–514CrossRefPubMed Stevic Z, Kostic-Dedic S, Peric S, Dedic V, Basta I, Rakocevic-Stojanovic V et al (2016) Prognostic factors and survival of ALS patients from Belgrade. Serbia Amyotroph Lateral Scler Frontotemporal Degener 17:508–514CrossRefPubMed
37.
go back to reference Chen L, Liu X, Tang L, Zhang N, Fan D (2016) Long-term use of riluzole could improve the prognosis of sporadic amyotrophic lateral sclerosis patients: a real-world cohort study in China. Front Aging Neurosci 8:246CrossRefPubMedPubMedCentral Chen L, Liu X, Tang L, Zhang N, Fan D (2016) Long-term use of riluzole could improve the prognosis of sporadic amyotrophic lateral sclerosis patients: a real-world cohort study in China. Front Aging Neurosci 8:246CrossRefPubMedPubMedCentral
Metadata
Title
Clinical and epidemiological characteristics of amyotrophic lateral sclerosis in an Egyptian cohort
Authors
Radwa Soliman
Enass Onbool
Kareem Omran
Nagia Fahmy
Publication date
30-09-2024
Publisher
Springer International Publishing
Published in
Neurological Sciences
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-024-07760-w

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Learn more